Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Test Type
6.1 Hearing Screening Test
6.2 Dry Blood Spot Test
6.3 Critical Congenital Heart Disease (CCHD) Test
Chapter 7 Market Segmentation by Product
7.1 Hearing screening devices and Accessories
7.2 Reagents and assay kits
7.3 Newborn disorder Screening Instruments
7.4 Pulse Oximetry
Chapter 8 Market Segmentation by Technology
8.1 DNA based assay
8.2 Electrophoresis
8.3 Hearing Screen Technology
8.4 Enzymes and Immunoassays
8.5 Tandem Mass Spectrometry
8.6 Pulse Oximetry Technology
Chapter 9 Market Segmentation by Geography
9.1 North America
9.1.1 Introduction
9.1.2 United States
9.1.3 Canada
9.1.4 Mexico
9.1.5 Others
9.2 Europe
9.2.1 Introduction
9.2.2 Spain
9.2.3 UK
9.2.4 France
9.2.5 Russia
9.2.6 Italy
9.2.7 Others
9.3 Asia Pacific
9.3.1 Introduction
9.3.2 China
9.3.3 India
9.3.4 Japan
9.3.5 Australia & New Zealand
9.3.6 Others
9.4 The Middle East and Africa
9.4.1 Introduction
9.4.2 South Africa
9.4.3 Middle East Countries
9.4.4 Others
9.5 South America
9.5.1 Introduction
9.5.2 Argentina
9.5.3 Brazil
9.5.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles
11.1 Covidien PLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2 PerkinElmer Inc.
11.3 Trivitron Healthcare
11.4 Masimo Corporation
11.5 AB Sciex LLC
11.6 Neogen Labs Pvt. Ltd.
11.7 Zen Tech S.A.
11.8 Natus Medical
11.9 Agilent Technologies
11.10 GE Healthcare
11.11 Cardinal Health, Inc.
11.12 Bio-Rad Laboratories
11.13 Medtronic Plc
11.14 Thermo Fisher Scientific, Inc.
11.15 Waters Corporation
Chapter 12 Market Estimates and Forecasting
12.1 Market Estimates and Forecasting 2018-2024(USD Million)
12.1.1 Market Estimation and Forecasting by Test Type 2018-2024 (USD Million)
12.1.2 Market Estimates and Forecasting by Product 2018-2024 (USD Million)
12.1.3 Market Estimates and Forecasting by Technology 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
